{"title":"Latency Immunity and Therapy","authors":"R. Duncan","doi":"10.1300/J092v05n02_05","DOIUrl":"https://doi.org/10.1300/J092v05n02_05","url":null,"abstract":"AbstractOrgan cells of the body retain an Immune Activity System comparable to protozoa. The cells' immunity memory templates are latent proteins, microbes, their toxins and chemicals (latentees). Excess latentees are detected and excreted by latency therapy. Their excretion induces immediate and/or delayed symptoms and signs recognized by the patient. Foreign latent materials (latentors) enter the body and bypass the natural immune system to be taken up selectively by organ cell groups. Active infection/disease and allergens (antigens) involve the natural immune system antibodies. Latent infection/disease and allergens (latentors) involve the Organ Cell Immunity as intracellu-lar latentees. Clinical laboratory testing is inappropriate.This Clinical Anecdotal Study compiles 297 patients who obtained little or no relief from conventional and alternative medicine (duration: 63% > three years). Patients provoked symptoms to two or more of 16 viruses, in particular Epstein Barr Virus. Latency therapy (heat, s...","PeriodicalId":350016,"journal":{"name":"Journal of Chronic Fatigue Syndrome","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117056770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Review and Hypothesis: Might Patients with the Chronic Fatigue Syndrome Have Latent Tetany of Magnesium Deficiency","authors":"M. Seelig","doi":"10.1300/J092V04N02_07","DOIUrl":"https://doi.org/10.1300/J092V04N02_07","url":null,"abstract":"The latent tetany syndrome (LTS) parallels CFS in its neuromuscular and psychiatric manifestations, as well as in inner ear disturbances: vestibular in CFS and FM, as well as in LTS, and increased vulnerability to noise-induced deafness in LTS. Microvascular damage to the cochlea is seen in Mg deficiency, noise-induced deafness, and might be a","PeriodicalId":350016,"journal":{"name":"Journal of Chronic Fatigue Syndrome","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115114915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pediatric Chronic Fatigue Syndrome and Munchausen-By-Proxy: A Case Study","authors":"E. Hoof, P. Becker, K. Meirleir","doi":"10.1300/J092V13N02_02","DOIUrl":"https://doi.org/10.1300/J092V13N02_02","url":null,"abstract":"AbstractPediatric chronic fatigue syndrome (CFS) posits even more challenges for professional caregivers in comparison with adult CFS samples. Most children with CFS display a decrease in school attendance and a decrease in social activities. As several conditions such as school phobia, primary psychiatric disorders or family disturbance present the same characteristics, the diagnostic process appears more complex. Family disturbance, moreover, is often specified as child abuse, neglect or even Munchausen-by-proxy. As skepticism is frequently associated with a diagnosis of CFS, patients and parents must fend for themselves, fighting allegations of child abuse and neglect. This case study illustrates what happens when such allegations are put forward.","PeriodicalId":350016,"journal":{"name":"Journal of Chronic Fatigue Syndrome","volume":"502 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2007-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116697128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. Oleske, K. Friedman, K. Kaufman, D. Palumbo, J. Sterling, Terri Lynn Evans
{"title":"Chronic fatigue syndrome in children and adolescents","authors":"J. Oleske, K. Friedman, K. Kaufman, D. Palumbo, J. Sterling, Terri Lynn Evans","doi":"10.1300/J092V13N02_07","DOIUrl":"https://doi.org/10.1300/J092V13N02_07","url":null,"abstract":"AbstractObjective: An overview of the unique aspects of Chronic Fatigue Syndrome in children and adolescents (CACFS) is herein provided for healthcare professionals who may be called upon to diagnose and/or treat this illness. Young age of onset, puberty, and interactions with peers and the educational system provide greater diagnostic and treatment challenges than found with adult onset CFS.Method: A review of diagnostic procedures and treatment protocols found in the contemporary literature is coupled with the professional experiences of the authors in treating CACFS to delineate the roles and responsibilities of family, healthcare providers and educators in diagnosing, treating and supporting the CACFS patient.Results: Areas discussed include: pathogenesis, patient evaluation, clinical evaluation, laboratory evaluation, treatment options, psychological issues, role of schools, and the roles of primary and tertiary care providers.Conclusion: CACFS can be diagnosed and treated with varying levels of succ...","PeriodicalId":350016,"journal":{"name":"Journal of Chronic Fatigue Syndrome","volume":"90 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2006-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126243107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
K. Jordan, L. Jason, C. Mears, B. Katz, A. Rademaker, C. Huang, J. Richman, W. McCready, Penny M. Ayers, Kari K. Taylor
{"title":"Prevalence of pediatric chronic fatigue syndrome in a community-based sample","authors":"K. Jordan, L. Jason, C. Mears, B. Katz, A. Rademaker, C. Huang, J. Richman, W. McCready, Penny M. Ayers, Kari K. Taylor","doi":"10.1300/J092V13N02_04","DOIUrl":"https://doi.org/10.1300/J092V13N02_04","url":null,"abstract":"AbstractBackground: This study evaluated the prevalence of chronic fatigue syndrome (CFS) among children and adolescents (ages 5 to 17) in an ethnically and socioeconomically diverse community population.Objectives: This investigation attempted to address limitations of previous studies by using a community-based sample and thoroughly evaluating each participant (i.e., using medical and psychological evaluations) to determine a proper diagnosis of CFS.Methods: A community-based sample of children and adolescents aged 5 to 17 were screened for symptoms of chronic fatigue syndrome by telephone. Those reported to suffer from CFS-like symptoms were given medical and psychological evaluations to allow a determination of the CFS diagnosis.Results: The overall prevalence rate for the sample was 60 per 100,000 or .06%. The prevalence for the adolescents (aged 13 to 17) was 181 per 100,000 or .181%.Conclusions: The current prevalence estimate for CFS in adolescents is higher than previous estimates. CFS was more c...","PeriodicalId":350016,"journal":{"name":"Journal of Chronic Fatigue Syndrome","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2006-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124955939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
K. Naranch, S. Repka-Ramirez, Y. Park, A. Velarde, R. Finnegan, J. Murray, A. Pheiffer, Eung Soo Hwang, D. Clauw, J. Baraniuk
{"title":"Differences in baseline nasal secretions between Chronic Fatigue Syndrome (CFS) and control subjects","authors":"K. Naranch, S. Repka-Ramirez, Y. Park, A. Velarde, R. Finnegan, J. Murray, A. Pheiffer, Eung Soo Hwang, D. Clauw, J. Baraniuk","doi":"10.1300/J092V10N01_02","DOIUrl":"https://doi.org/10.1300/J092V10N01_02","url":null,"abstract":"AbstractObjective: To assess potential mechanism(s) for the rhinitis found in Chronic Fatigue Syndrome (CFS) subjects.Methods: The concentrations of mucus constituents were measured in basal nasal lavage fluids of 103 CFS and 92 non-CFS control subjects. Subjects were further characterized by their Rhinitis Score and allergy skin test results into nonallergic and allergic rhinitis, atopic, and negative subgroups to determine if differences were related to atopy. Other questionnaires of irritant sensitivity and medicine use were completed.Results: Mucin polysaccharide (p = 0.043, ANOVA), free hemoglobin (p = 0.0044), mucin/total protein (p = 0.039) and hemoglobin/total protein (p = 0.043) were higher in CFS than controls. CFS subjects with positive Rhinitis Scores (p = 0.023) or skin tests (p = 0.047) had higher mucin levels than those with negative values. For all subjects, increased mucin was correlated with total protein (Pearson's r2 = 0.188) and inhaled corticosteroid use (r2 = 0.091), while hemoglobi...","PeriodicalId":350016,"journal":{"name":"Journal of Chronic Fatigue Syndrome","volume":"104 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122579358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Severe CFS/ME of Juvenile Onset— A Report from the CHROME Database","authors":"R. Gibbons, D. Pheby, C. Richards, F. Bray","doi":"10.1300/J092V04N04_06","DOIUrl":"https://doi.org/10.1300/J092V04N04_06","url":null,"abstract":"AbstractCHROME has been collecting data since 1995 on very severely disabled patients in the UK with ME, in order to assess aspects of physical and cognitive levels of disability at the onset of the illness and to monitor progress. Results of the first two years data (225 cases) collection are reported.The modal age of onset for this severe group of patients was 11-15, and the proportion increased with more recent years of onset. Patients tended to deteriorate between onset and recruitment in cognitive and functional ability, and in sensory and sleep disturbance. Statistical significance was assessed using McNemar's Test for comparing correlated proportions.","PeriodicalId":350016,"journal":{"name":"Journal of Chronic Fatigue Syndrome","volume":"88 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114608428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
L. Jason, M. Ropacki, Nicole Santoro, J. Richman, Wendy Heatherly, Renée R Taylor, J. Ferrari, Trina M. Haney-Davis, A. Rademaker, J. Dupuis, J. Golding, A. Plioplys, S. Plioplys
{"title":"A Screening Instrument for Chronic Fatigue Syndrome: Reliability and Validity","authors":"L. Jason, M. Ropacki, Nicole Santoro, J. Richman, Wendy Heatherly, Renée R Taylor, J. Ferrari, Trina M. Haney-Davis, A. Rademaker, J. Dupuis, J. Golding, A. Plioplys, S. Plioplys","doi":"10.1300/J092V03N01_04","DOIUrl":"https://doi.org/10.1300/J092V03N01_04","url":null,"abstract":"AbstractBecause estimates of the prevalence of Chronic Fatigue Syndrome (CFS) have been quite variable, there is a need for a screening instrument and second stage medical assessment that will produce the most valid estimate of the CFS prevalence. In the present study, four groups of 15 subjects each were recruited: patients diagnosed with (1) CFS, (2) Lupus, (3) Multiple Sclerosis (MS), and (4) a healthy control group. Participants were interviewed twice over a two week period of time with a screening instrument comprising The Fatigue Scale and a newly configured section. The screening instrument had excellent test-retest and interrater reliability. This screening instrument therefore has utility for CFS community-based epidemiologic research. However, while the instrument differentiates patients with CFS from those who are healthy, it is less likely to distinguish CFS from other autoimmune diseases (especially Lupus). Thus, future community-based CFS prevalence studies should encompass both a screening ...","PeriodicalId":350016,"journal":{"name":"Journal of Chronic Fatigue Syndrome","volume":"80 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1997-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123550503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Lipid Replacement and Antioxidant Nutritional Therapy for Restoring Mitochondrial Function and Reducing Fatigue in Chronic Fatigue Syndrome and Other Fatiguing Illnesses","authors":"G. Nicolson, Rita R. Ellithorpe","doi":"10.1300/J092V13N01_06","DOIUrl":"https://doi.org/10.1300/J092V13N01_06","url":null,"abstract":"Evidence in the literature indicates that diminished mitochondrial function through loss of efficiency in the electron transport chain caused by oxidation occurs during aging and in fatiguing illnesses. Lipid Replacement Therapy (LRT) administered as a nutritional supplement with antioxidants can prevent oxidative membrane damage, and LRT can be used to restore mitochondrial and other cellular membrane functions via delivery of undamaged replacement lipids to cellular organelles. Recent clinical trials using patients with chronic fatigue have shown the benefit of LRT plus antioxidants in restoring mitochondrial electron transport function and reducing moderate to severe chronic fatigue. These studies indicate the benefits of LRT plus antioxidants in reducing fatigue and preventing loss of mitochondrial function, most likely by protecting mitochondrial and other cellular membranes from oxidative and other damage and removing damaged lipids by lipid replacement. In one clinical study we determined if mitochondrial function is reduced in subjects with mild to severe chronic fatigue, and if this can be reversed with NTFactor®, a nutritional supplement that replaces damaged cellular lipids. Using the Piper Fatigue Scale there was a significant time-dependent reduction in overall fatigue in moderately or severely fatigued subjects while on the dietary supplement for 4-8 weeks. Analysis of mitochrondrial function indicated that four and eight weeks of the dietary supplement in moderately or severely fatigued subjects significantly increased mitochondrial function. Similarly, chronic fatigue syndrome patients administered antioxidants plus LRT also show reductions in fatigue. The results indicate that LRT plus antioxidants can significantly reduce moderate to severe chronic fatigue and restore mitochondrial function. Dietary use of unoxidized membrane lipids plus antioxidants is recommended for patients with moderate to severe chronic fatigue.","PeriodicalId":350016,"journal":{"name":"Journal of Chronic Fatigue Syndrome","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124364533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}